ATOTO CB7 Pro 301% Funded--Head‑Unit AI Console for Wireless CarPlay/Android Auto and Camera‑Smart Driving
SHENZHEN, China, Jan. 23, 2026 /PRNewswire/ -- ATOTO shared an update on CB7 Pro, its Head-Unit AI Console. It's built on a simple philosophy: don't replace the factory screen—give it new capabilities. CB7 Pro plugs into the USB port used for wired...
HTX's 2025 Listing Strategy Review, Building a High-Liquidity Ecosystem Through First-Mover Advantage and Longtermism
PANAMA CITY, Jan. 23, 2026 /PRNewswire/ -- In 2025, persistent macro uncertainty and rapidly shifting crypto narratives turned asset selection into a defining pillar of exchange competitiveness. Over the course of the year, HTX, the global leading...
NYSE Content Advisory: Pre-Market Update + Crypto Infrastructure Company BitGo Rises 2.7% in NYSE Debut
NEW YORK, Jan. 23, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content...
Spanning seven decades, how China and African countries build an all-weather community with a shared future?
BEIJING, Jan. 23, 2026 /PRNewswire/ -- A news report from China.org.cn on China-Africa cooperation over the past seven decades: Spanning seven decades, how China and African countries build an all-weather community with a shared future? As China and...
CGTN Art Series | Digital expo China Crafted wins hearts at ART SG
SINGAPORE, Jan. 23, 2026 /PRNewswire/ -- CGTN launched China Crafted, the latest season of its CGTN Art Series, alongside a curated display of the previous three seasons of the series at ART SG 2026 in Singapore on Friday. Notable personalities as...
CANEUS & Government of Maharashtra Announce Partnership at WEF Davos
To Establish World's First Global Mid-TRL Innovation Acceleration and Skilling Institute for Aerospace, Space, Energy and Deep Technology DAVOS, Switzerland, Jan. 23, 2026 /PRNewswire/ -- CANEUS International, in partnership with the Government of...
Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor
Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) paves the way for ISM8969 clinical study in the United States. The Phase I clinical trial aims to evaluate safety, tolerability, and pharmacokinetics profiles....
"From Page to Stage®" Brings Taming the Dragon to the Stage this March
The Final Chapter of the "Three Kingdoms Trilogy" Fusing Arts & Tech in an Epic English Showdown HONG KONG, Jan. 23, 2026 /PRNewswire/ -- The Absolutely Fabulous Theatre Connection (AFTEC), dedicated to integrating the Bilingual Learning...